Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_PHASE1
138
about 2.8 years
18–65
1 site in CA
Why this study is shown
What this study is about
Researchers are testing how different cannabis treatments affect cognitive functions like decision-making and attention in people with HIV. The trial will also measure levels of endocannabinoids (chemicals that interact with the body's natural cannabinoid system) to see if cannabis use impacts these systems.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 10 mg Δ9-tetrahydrocannabinol (THC)
- 2.Take 600 mg cannabidiol (CBD)
- 3.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
dronabinol, cannabidiol, cannabinoid
oral (Oral Solution)
Immune, Infectious